Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:9185272.
doi: 10.1155/2017/9185272. Epub 2017 Oct 31.

Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects

Affiliations

Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects

Francesco Piarulli et al. Oxid Med Cell Longev. 2017.

Abstract

This study aims to assess the proinflammatory interleukin 1β (IL-1β) and anti-inflammatory IL-10 production by monocytes from 38 patients with type 2 diabetes and 31 controls in different glucose concentrations. Monocytes were incubated in low (2.5 mmol/L)-, normal (5.0 mmol/L)-, and high (20 mmol/L)-glucose conditions in the presence and absence of lipopolysaccharide (LPS). Monocytes from both patients and controls only produced a significant increase in IL-1β in low-glucose conditions (p < 0.01), and this phenomenon was amplified in the presence of LPS, while it was not seen in normal- or high-glucose conditions, not even in the presence of LPS stimulation. There was no increase in IL-10 production by monocytes from either diabetic patients or controls using whatever glucose concentrations, except when treated with LPS in normal-glucose conditions. These findings seem to suggest that low-glucose conditions induce an inflammatory response in monocytes in all individuals, as an intrinsic capacity of this cell line. On the other hand, monocytes only retain their anti-inflammatory ability in response to known inflammatory stimuli such as LPS, under normal-glucose concentrations. In conclusion, human monocytes express an inflammatory pattern in low-glucose conditions in vitro. This response could contribute to explaining the higher cardiovascular risk induced by hypoglycemia in diabetic patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IL-1β released by monocytes obtained from diabetic patients (n = 38) and control subjects (n = 31). (a) Basal conditions. (b) After stimulation with LPS (1 μg/mL). Dot plots show individual absolute values measured in the culture medium at different glucose concentrations: glucose 2.5 mmol/L, 5.0 mmol/L, and 20 mmol/L. Graphs are completed with box plots, where the ends of the box represent the 25th and 75th quantiles, respectively, while the horizontal line within the box represents the median value; whiskers extend the distances computed as 1st quartile − 1.5 × interquartile range and 3rd quartile + 1.5 × interquartile range. Following a significant two-way ANOVA, comparisons between glucose concentrations have been evaluated as paired data (see Table 2 for detailed statistics). No significant differences were detected with one-way ANOVA between controls and diabetic patients at each glucose concentration.

References

    1. Schwartz C. J., Valente A. J., Sprague E. A., Kelley J. L., Cayatte A. J., Rozek M. M. Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus. Diabetes Care. 1992;15(9):1156–1167. doi: 10.2337/diacare.15.9.1156. - DOI - PubMed
    1. Piarulli F., Sartore G., Lapolla A. Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update. Acta Diabetologica. 2013;50(2):101–110. doi: 10.1007/s00592-012-0412-3. - DOI - PMC - PubMed
    1. Dinarello C. A., Donath M. Y., Mandrup-Poulsen T. Role of IL-1β in type 2 diabetes. Current Opinion in Endocrinology, Diabetes & Obesity. 2010;17(4):314–321. doi: 10.1097/MED.0b013e32833bf6dc. - DOI - PubMed
    1. Dasu M. R., Devaraj S., Jialal I. High glucose induces IL-1β expression in human monocytes: mechanistic insights. American Journal of Physiology. Endocrinology and Metabolism. 2007;293(1):E337–E346. doi: 10.1152/ajpendo.00718.2006. - DOI - PMC - PubMed
    1. Fearon W. F., Fearon D. T. Inflammation and cardiovascular disease. Role of the interleukin-1 receptor antagonist. Circulation. 2008;117(20):2577–2579. doi: 10.1161/CIRCULATIONAHA.108.772491. - DOI - PubMed

MeSH terms

LinkOut - more resources